LOC100286922: A Drug Target / Disease Biomarker (G100286922)
LOC100286922: A Drug Target / Disease Biomarker
LOC100286922 is a protein that is expressed in various tissues of the body, including the brain, heart, and kidneys. It is a member of the known as the LOC100286922 family of proteins, which are characterized by their unique structure and the presence of a hypervariable region (HVR) in their coding regions.
One of the most interesting aspects of LOC100286922 is its potential as a drug target. The HVR region of LOC100286922 has been identified as a potential drug target, due to its unique structure and the presence of various chemical modifications in the HVR region. These modifications have led to the formation of a distinct region that is targeted by small molecules, such as drugs.
In addition to its potential as a drug target, LOC100286922 also has a strong potential as a biomarker. The protein is highly expressed in various tissues of the body, including the brain, heart, and kidneys, which makes it a potential marker for a variety of diseases, such as neurodegenerative disorders, cardiovascular disease, and kidney disease.
The discovery of LOC100286922 as a potential drug target and biomarker has significant implications for the development of new treatments for a variety of diseases. By targeting the HVR region of LOC100286922 with small molecules, researchers may be able to develop new treatments for conditions such as Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders.
In addition to its potential as a drug target, LOC100286922 also has a strong potential as a biomarker. The protein is highly expressed in various tissues of the body, including the brain, heart, and kidneys, which makes it a potential marker for a variety of diseases, such as neurodegenerative disorders, cardiovascular disease, and kidney disease.
The discovery of LOC100286922 as a potential drug target and biomarker has significant implications for the development of new treatments for a variety of diseases. By targeting the HVR region of LOC100286922 with small molecules, researchers may be able to develop new treatments for conditions such as Alzheimer's disease, Parkinson's disease, and other neurodegenerative disorders. Additionally, the protein's strong expression in various tissues makes it a potential biomarker for a variety of diseases.
Protein Name: DnaJ Heat Shock Protein Family (Hsp40) Member B3 Pseudogene
More Common Targets
LOC100287036 | LOC100287290 | LOC100287329 | LOC100287413 | LOC100287792 | LOC100287834 | LOC100287846 | LOC100287944 | LOC100288069 | LOC100288162 | LOC100288208 | LOC100288637 | LOC100288656 | LOC100289230 | LOC100289283 | LOC100289308 | LOC100289333 | LOC100289361 | LOC100289470 | LOC100289473 | LOC100289495 | LOC100289511 | LOC100289561 | LOC100289580 | LOC100289656 | LOC100293211 | LOC100294145 | LOC100335030 | LOC100419773 | LOC100420587 | LOC100421561 | LOC100505498 | LOC100505502 | LOC100505585 | LOC100505664 | LOC100505715 | LOC100505716 | LOC100505841 | LOC100505912 | LOC100505915 | LOC100505978 | LOC100506023 | LOC100506071 | LOC100506076 | LOC100506124 | LOC100506207 | LOC100506236 | LOC100506274 | LOC100506281 | LOC100506379 | LOC100506403 | LOC100506422 | LOC100506444 | LOC100506446 | LOC100506472 | LOC100506474 | LOC100506499 | LOC100506514 | LOC100506532 | LOC100506606 | LOC100506634 | LOC100506639 | LOC100506667 | LOC100506730 | LOC100506974 | LOC100507002 | LOC100507006 | LOC100507053 | LOC100507054 | LOC100507156 | LOC100507165 | LOC100507221 | LOC100507250 | LOC100507336 | LOC100507346 | LOC100507351 | LOC100507389 | LOC100507412 | LOC100507424 | LOC100507443 | LOC100507513 | LOC100507520 | LOC100507547 | LOC100507577 | LOC100507656 | LOC100509646 | LOC100533709 | LOC100630923 | LOC100652743 | LOC100652768 | LOC100652833 | LOC100652999 | LOC100653061 | LOC100996385 | LOC100996412 | LOC100996583 | LOC100996637 | LOC100996643 | LOC100996664 | LOC100996770
